Subscribe
shutterstock_1017347380_sundryphotography
sundryphotography / Shutterstock.com
18 February 2019Americas

J&J to buy surgical robotics company for $3.4bn

Johnson & Johnson (J&J) has  announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.
Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.
Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

More on this story

Americas
Surgical device maker hit with $10m damages in stapler patent dispute
20 October 2022   Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.
Big Pharma
Johnson & Johnson braces for Q3 sales dip as generics bite
18 July 2019   Johnson & Johnson has warned that strong competition from generic drugs could impact the company’s figures for the rest of the year.
Americas
J&J to acquire Verily stake in Verb Surgical
23 December 2019   Johnson & Johnson has announced its plan to acquire the remaining stake in Verb Surgical, its robotics venture with Alphabet-owned Verily.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers